Full text

Turn on search term navigation

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

SARS-CoV-2 outbreaks on 69 Dutch mink farms in 2020 were studied to identify risk factors for virus introduction and transmission and to improve surveillance and containment measures. Clinical signs, laboratory test results, and epidemiological aspects were investigated, such as the date and reason of suspicion, housing, farm size and distances, human contact structure, biosecurity measures, and presence of wildlife, pets, pests, and manure management. On seven farms, extensive random sampling was performed, and age, coat color, sex, and clinical signs were recorded. Mild to severe respiratory signs and general diseases such as apathy, reduced feed intake, and increased mortality were detected on 62/69 farms. Throat swabs were more likely to result in virus detection than rectal swabs. Clinical signs differed between virus clusters and were more severe for dark-colored mink, males, and animals infected later during the year. Geographical clustering was found for one virus cluster. Shared personnel could explain some cases, but other transmission routes explaining farm-to-farm spread were not elucidated. An early warning surveillance system, strict biosecurity measures, and a (temporary) ban on mink farming and vaccinating animals and humans can contribute to reducing the risks of the virus spreading and acquisition of potential mutations relevant to human and animal health.

Details

Title
Manifestation of SARS-CoV-2 Infections in Mink Related to Host-, Virus- and Farm-Associated Factors, The Netherlands 2020
Author
Wolters, Wendy J 1 ; Myrna M T de Rooij 2 ; Molenaar, Robert Jan 3   VIAFID ORCID Logo  ; de Rond, Jan 3 ; Vernooij, J C M 1   VIAFID ORCID Logo  ; Meijer, Paola A 4 ; Bas B Oude Munnink 5 ; Sikkema, Reina S 5   VIAFID ORCID Logo  ; Arco N van der Spek 6 ; Spierenburg, Marcel A H 6 ; Renate W Hakze-van der Honing 7   VIAFID ORCID Logo  ; Wim H M van der Poel 7   VIAFID ORCID Logo  ; Koopmans, Marion P G 5   VIAFID ORCID Logo  ; Stegeman, J Arjan 1   VIAFID ORCID Logo  ; Smit, Lidwien A M 2   VIAFID ORCID Logo  ; Augustijn-Schretlen, Marieke 3 ; Velkers, Francisca C 1   VIAFID ORCID Logo 

 Department of Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, The Netherlands 
 Institute for Risk Assessment Sciences (IRAS), Utrecht University, 3584 CM Utrecht, The Netherlands 
 Royal GD, 7418 EZ Deventer, The Netherlands 
 Department of Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, The Netherlands; Royal GD, 7418 EZ Deventer, The Netherlands 
 Department of Viroscience, Erasmus MC, 3015 GD Rotterdam, The Netherlands 
 Netherlands Food and Consumer Product Safety Authority (NVWA), 3511 GG Utrecht, The Netherlands 
 Wageningen Bioveterinary Research, 8221 RA Lelystad, The Netherlands 
First page
1754
Publication year
2022
Publication date
2022
Publisher
MDPI AG
e-ISSN
19994915
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2706423962
Copyright
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.